Explore more publications!

Harrisburg Wellness Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Wellness Reporter.

Press releases published on September 9, 2025

OK2StandUP Inc. Selected to Exhibit OK2StandUP System at Vizient Innovative Technology Exchange
MoodRx Addresses Cost and Access Barriers with Insurance and  Online Therapy and Screening for Seniors and Young Adults
HoodTalk Music Festville Goes Global Through Twin Eagle Trade Partnership
On Time Edge Announces Manufacturing Scheduling Summit 2025: Here’s What to Expect
Transcell Biologics & New Frontier Labs with 20/15 Visioneers Unite to Advance Non-Animal Molecular Discovery Approaches
NPF Invites Philadelphia to Take ACTION for Psoriatic Disease
Silver Lining Clinics Expands Access to Medicare-Covered Online Therapy as Loneliness Epidemic Hits Pennsylvania Seniors
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
Significant Breakthrough! eefit Far Infrared Technology Improves Two Major Symptoms of Alzheimer’s Disease, Bringing New Hope to Brain Health Protection
University Hospital Foundation announces project to support Alberta dementia patients and their families
Actuate Therapeutics Announces Proposed Public Offering of Common Stock
Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2025
Picard Medical, Inc. Announces Exercise of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
Celcuity Announces Upsized Senior Secured Term Loan Facility of $500 Million with Innovatus Capital Partners and Oxford Finance
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025
Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease
Tevogen Estimates 5-Year Top-Line Revenue of ∼$6.5 Billion For Product Focused on Liver Cancer Prevention with High-Risk Chronic Hepatitis B Infection
KFSHRC Concludes Strategic Role at C3 Davos of Healthcare New York Summit

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions